Impact of Winter Supplementation of May Calving Cows and Heifer Development System in Two Different Breeding Seasons on Subsequent Growth and Reproduction

In Exp. 1, May-calving cows were utilized to evaluate the effects of winter supplementation on heifer progeny. Cows grazed either dormant upland winter range with or without a protein supplement or grazed dormant meadow with or without a protein supplement. In Exp. 2, replacement heifers from March and May calving herds were offered ad libitum meadow hay and 4 lb/d supplement or grazed meadow and offered 1 lb/d supplement from mid-January to mid-April. Calf weaning BW and ADG from birth to weaning was less for calves from cows grazing winter range with no supplement compared with all other dam treatments. Heifer development system did not impact final pregnancy rates. Therefore, a reduced input winter heifer development system is a viable option in both early and late summer breeding seasons. However, winter supplementation of May-calving dams did influence heifer progeny ADG from birth to weaning

Synthesis, photophysics and molecular structures of luminescent 2,5-bis(phenylethynyl)thiophenes (BPETs)

International audienceThe Sonogashira cross-coupling of two equivalents of para-substituted ethynylbenzenes with 2,5-diiodothiophene provides a simple synthetic route for the preparation of 2,5-bis(para-R-phenylethynyl)thiophenes (R = H, Me, OMe, CF3, NMe2, NO2, CN and CO2Me) (1a-h). Likewise, 2,5-bis(pentafluorophenylethynyl)thiophene (2) was prepared by the coupling of 2,5-diiodothiophene with pentafluorophenylacetylene. All compounds were characterised by NMR, IR, Raman and mass spectroscopy, elemental analysis, and their absorption and emission spectra, quantum yields and lifetimes were also measured. The spectroscopic studies of 1a-h and 2 show that both electron donating and electron withdrawing para-subsituents on the phenyl rings shift the absorption and emission maxima to lower energies, but that acceptors are more efficient in this regard. The short singlet lifetimes and modest fluorescence quantum yields (ca. 0.2-0.3) observed are characteristic of rapid intersystem crossing. The single-crystal structures of 2,5-bis(phenylethynyl)thiophene, 2,5-bis(para-carbomethoxyphenylethynyl)thiophene, 2,5-bis(para-methylphenylethynyl)thiophene and 2,5-bis(pentafluorophenylethynyl)thiophene were determined by X-ray diffraction at 120 K. DFT calculations show that the all-planar form of the compounds is the lowest in energy, although rotation of the phenyl groups about the C[triple bond, length as m-dash]C bond is facile and TD-DFT calculations suggest that, similar to 1,4-bis(phenylethynyl)benzene analogues, the absorption spectra in solution arise from a variety of rotational conformations. Frequency calculations confirm the assignments of the compounds' IR and Raman spectra

The clinical and molecular spectrum of galactosemia in patients from the Cape Town region of South Africa

BACKGROUND: The objective of this study was to document the clinical, laboratory and genetic features of galactosemia in patients from the Cape Town metropolitan region. METHODS: Diagnoses were based on thin layer chromatography for galactosuria/galactosemia and assays of erythrocyte galactose-1-phosphate uridyltransferase (GALT) and galactokinase activities. Patients were screened for the common S135L and Q188R transferase gene mutations, using PCR-based assays. Screening for the S135L mutation in black newborns was used to estimate the carrier rate for galactosemia in black South Africans. RESULTS: A positive diagnosis of galactosemia was made in 17 patients between the years 1980 to 2001. All had very low or absent galactose-1-phosphate uridyltransferase (GALT) activity, and normal galactokinase levels. The mean age at diagnosis was 5.1 months (range 4 days to 6.5 months). A review of 9 patients showed that hepatomegaly (9/9), and splenomegaly, failure to thrive, developmental delay, bilateral cataracts (6/9) were the most frequent features at diagnosis. Six had conjugated hyperbilirubinemia. Four experienced invasive E. coli infection before diagnosis. Ten patients were submitted to DNA analysis. All 4 black patients and 2 of mixed extraction were homozygous for the S135L allele, while all 3 white patients were homozygous for the Q188R allele. The remaining patient of mixed extraction was heterozygous for the Q188R allele. The estimated carrier frequency of the S135L mutation in 725 healthy black newborns was 1/60. CONCLUSIONS: In the absence of newborn screening the delay in diagnosis is most often unacceptably long. Also, carrier frequency data predict a galactosemia incidence of approximately 1/14 400 for black newborns in the Cape Metropole, which is much higher than the current detection rate. It is thus likely that many patients go undetected

Mucopolysaccharidosis VI

Mucopolysaccharidosis VI (MPS VI) is a lysosomal storage disease with progressive multisystem involvement, associated with a deficiency of arylsulfatase B leading to the accumulation of dermatan sulfate. Birth prevalence is between 1 in 43,261 and 1 in 1,505,160 live births. The disorder shows a wide spectrum of symptoms from slowly to rapidly progressing forms. The characteristic skeletal dysplasia includes short stature, dysostosis multiplex and degenerative joint disease. Rapidly progressing forms may have onset from birth, elevated urinary glycosaminoglycans (generally >100 μg/mg creatinine), severe dysostosis multiplex, short stature, and death before the 2nd or 3rd decades. A more slowly progressing form has been described as having later onset, mildly elevated glycosaminoglycans (generally <100 μg/mg creatinine), mild dysostosis multiplex, with death in the 4th or 5th decades. Other clinical findings may include cardiac valve disease, reduced pulmonary function, hepatosplenomegaly, sinusitis, otitis media, hearing loss, sleep apnea, corneal clouding, carpal tunnel disease, and inguinal or umbilical hernia. Although intellectual deficit is generally absent in MPS VI, central nervous system findings may include cervical cord compression caused by cervical spinal instability, meningeal thickening and/or bony stenosis, communicating hydrocephalus, optic nerve atrophy and blindness. The disorder is transmitted in an autosomal recessive manner and is caused by mutations in the ARSB gene, located in chromosome 5 (5q13-5q14). Over 130 ARSB mutations have been reported, causing absent or reduced arylsulfatase B (N-acetylgalactosamine 4-sulfatase) activity and interrupted dermatan sulfate and chondroitin sulfate degradation. Diagnosis generally requires evidence of clinical phenotype, arylsulfatase B enzyme activity <10% of the lower limit of normal in cultured fibroblasts or isolated leukocytes, and demonstration of a normal activity of a different sulfatase enzyme (to exclude multiple sulfatase deficiency). The finding of elevated urinary dermatan sulfate with the absence of heparan sulfate is supportive. In addition to multiple sulfatase deficiency, the differential diagnosis should also include other forms of MPS (MPS I, II IVA, VII), sialidosis and mucolipidosis. Before enzyme replacement therapy (ERT) with galsulfase (Naglazyme®), clinical management was limited to supportive care and hematopoietic stem cell transplantation. Galsulfase is now widely available and is a specific therapy providing improved endurance with an acceptable safety profile. Prognosis is variable depending on the age of onset, rate of disease progression, age at initiation of ERT and on the quality of the medical care provided

Spring versus Summer Calving for the Nebraska Sandhills: Production Characteristics

Effects of summer calving versus traditional spring calving were investigated over three years. Calving dates were: 1) March to April (beginning March 18) for spring calving and 2) mid-June to mid-August (beginning June 18) for summer calving. Spring-born calves were weaned in October, while summer-born calves were weaned in November or January. Summer calving cows were bred either on native range or subirrigated meadow. Birth weights were higher for summer-born calves, although weaning weights were lower. Pregnancy rates for spring-calving cows bred on native range were similar to summer-calving cows bred on subirrigated meadow or native range. Summer calving reduced the amount of hay necessary to winter the cow herd by about 3,150 lb/hd/year. The amount of supplement fed/cow/ year was similar for spring and summer calving cows. Summer calving offers significant feed and labor savings for cow-calf producers

Supplementing Metabolizable Protein to Yearling Heifers Grazing Winter Range

Two experiments were conducted with pregnant yearling heifers grazing Sandhills winter range to evaluate response of supplementing to meet the metabolizable protein requirement of the heifers versus conventional supplementation based on crude protein. Supplements were fed from October to February (pre-calving) both years. Intake was measured in November, January and February of the first year. Supplementing to meet metabolizable protein requirement improved the heifers’ ability to maintain weight in year one, but not in year two. Heifer intakes ranged from 2.2% of BW in November to 1.5% in February. Feeding hay reduced body weight loss compared to no hay feeding in year two

Effect of Gestation and Supplementation on Intake of Low-Quality Forage

Eighteen spring-calving heifers were paired by expected calving date and assigned to treatment. Treatments were a high undegradable intake protein supplement (CON) or one based on dry corn gluten feed (TRT). Heifers were fed to consume low-quality hay ad libitum. Supplement type did not affect body condition, milk production, or calf ADG. TRT heifers lost less weight than CON heifers. There was no effect of supplement on forage intake. Intake changed cubically with respect to calving; decreasing 17% during the three weeks prior to calving, and increasing 18% the week after calving